By observing serum insulin secretion and blood glucose concentration in rats, it was found that L-theanine downregulated the expression of SGLT3 and GLUT5 in the intestinal tract, leading to the inhibition of glucose uptake in the small intestine (78)
metformin, sulfonylureas, TZDs, etc.) address only one of the underlying pathophysiology - lowering postprandial glucose levels, but their safety profiles and side effects, such as weight gain and hypoglycemia, may present challenges and limitations in their clinical use
This is a decision you and your doctor will make together based on your progress
Out of 307 participants who initiated dialysis during the study, 50% on semaglutide and 56% on placebo continued medication post-dialysis initiation
Most importantly, neither agent has raised major red flags in terms of serious adverse events in the trials conducted to date